Treatment options for patients with left main coronary artery disease

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Cardiac Surgery

Background:

• Coronary artery bypass grafting (CABG) is the established treatment for left main coronary artery disease.
• Percutaneous coronary intervention (PCI) is an alternative for patients unsuitable for CABG.
• CABG involves prolonged recovery and variable graft longevity, necessitating alternative strategies.

Observation:

• Drug-eluting stents (DES) have shown reduced restenosis rates compared to bare metal stents.
• DES implantation has demonstrated clinical outcomes comparable to CABG in select patient populations.
• Isolated left main disease, particularly ostial or midbody lesions, is associated with favorable outcomes following PCI.

Findings:

• Patients with specific left main disease characteristics may achieve good clinical results with low rates of restenosis and stent thrombosis using DES.
• The choice between CABG and PCI with DES depends on individual patient factors and lesion complexity.
• Ongoing trials like EXCEL are crucial for defining the optimal revascularization approach.

Implications:

• PCI with DES presents a viable and potentially less invasive alternative to CABG for selected patients with left main disease.
• Further research will refine patient selection criteria for PCI versus CABG, optimizing treatment strategies.
• Advancements in stent technology continue to improve outcomes for percutaneous coronary interventions in complex coronary artery disease.